ELAVL1 and neoplasm: Subsequently, we evaluated tumorigenic conditions in mice and observed that the downregulation of ELAVL1 remarkably hindered graft tumor growth, as indicated by reduced tumor size, tumor growth curve and weight (Fig. 7C-E).